Drug intelligence / Profile preview

Combined Sheep Mycoplasma Pneumoniae, Parainfluenza 3 Virus and M. haemolytica Inactivated Vaccine

Development stage: Preclinical
Lead developer: Spirit Jinyu Biological Pharmaceutical
Modality: Vaccines & Immunotherapeutics
Administration: Subcutaneous

Overview

Combined Sheep Mycoplasma Pneumoniae, Parainfluenza 3 Virus and M. haemolytica Inactivated Vaccine is a trivalent veterinary inactivated vaccine candidate in Jinyu Biotechnology's ruminant-vaccine pipeline. It is intended to induce protective active immune responses against *Mycoplasma pneumoniae*, parainfluenza 3 virus, and *Mannheimia haemolytica* for prevention of respiratory disease associated with these pathogens in sheep.

Other names: mycoplasma pneumoniae inactivated vaccine + parainfluenza 3 virus inactivated vaccine + mannheimia haemolytica inactivated vaccine

Beyond the preview

Go deeper on Combined Sheep Mycoplasma Pneumoniae, Parainfluenza 3 Virus and M. haemolytica Inactivated Vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Combined Sheep Mycoplasma Pneumoniae, Parainfluenza 3 Virus and M. haemolytica Inactivated Vaccine.

Explore the full profile